Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
PureTech Health, the clinical-stage biotherapeutics company, has announced that Julie Krop M.D. has been appointed chief medical officer of the company.
Krop will manage all clinical development, among other things, for the companys pipeline.
We are pleased to welcome Julie to our senior leadership team as our Wholly Owned Pipeline rapidly grows and advances across multiple areas of significant patient need, said Daphne Zohar, founder and chief executive officer of PureTech.
Julie is a biopharmaceutical industry veteran with a wide breadth of expertise across multiple therapeutic areas and orphan indications.
Krop joins FreeTech from Freeline Therapeutics where she served as chief medical officer.